Mps1-IN-2,
1228817-38-6,
MPS1IN2,
9-Cyclopentyl-2-(2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenylamino)-5-methyl-8,9-dihydro-5H-pyrimido[5,4-b][1,4]diazepin-6(7H)-one,
9-cyclopentyl-2-{[2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino}-5-methyl-5H,6H,7H,8H,9H-pyrimido[4,5-b][1,4]diazepin-6-one,
Scaffold, B13,
SCHEMBL618437,
CHEMBL3974629,
BDBM36486,
BCP19164,
EX-A1000,
MFCD28167735,
ZINC62260347,
AKOS026750230,
Mps1-IN-2, >=98% (HPLC),
NCGC00386761-02,
BC600557,
DA-47027,
HY-13994,
FT-0735611,
2-[[2-Ethoxy-4-(4-hydroxypiperidino)phenyl]amino]-5-methyl-9-cyclopentyl-8,9-dihydro-5H-pyrimido[4,5-b][1,4]diazepine-6(7H)-one,
9-cyclopentyl-2-(2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenylamino)-5-methyl-8,9-dihydro-5h-pyrimido[4,5-b][1,4]diazepin-6(7h)-one,
9-cyclopentyl-2-[2-ethoxy-4-(4-hydroxypiperidin-1-yl)anilino]-5-methyl-7,8-dihydropyrimido[4,5-b][1,4]diazepin-6-one,
CS-2027,
B1138,
9-Cyclopentyl-2-[[2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino]-5-methyl-8,9-dihydro-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one,